The FDA’s approval of GSK’s new malaria drug Tafenoquine (Krintafel) provokes a mixed response and a research team from the ANU and The University of Queensland make a ‘small fragment of human protein’ that kills the microbial parasite that causes malaria.
The Britsh healthcare company, GSK, has partnered with US biotechnology company, 23andMe. GSK now has access to their vast database of DNA to drive drug research. Here’s an overview of what this could mean for the future of pharmaceutical R&D.
In this episode of Five Minutes, we speak with Thomas Stewart, a Programme Manager from The Mentor Initiative. He tells us about his work in malaria control and why it’s now more important than ever to eliminate malaria.
We speak with Professor Jake Baum of Imperial College London. He has been thrust in the spotlight for what the ‘Independent’ is calling a ‘major malaria breakthrough’. His team is working on trying to find a set of compounds that stop mosquitoes from contracting malaria when they bite an infected person.
Anti-malaria drug Tafenoquine comes under fire after claims of neuropsychiatric side effects, NIH researchers block parasites entering the bloodstream, Jigawa distributes 3.5 million mosquito nets, Nigeria loses 300 billion Naira to malaria and the Malaria World Congress calls on the global community to work together.
The PMI VectorLink Project is equipping countries to plan and implement sustainable Indoor Residual Spraying programs and other life-saving malaria control interventions. I wanted to know what’s changed in the malaria field and what they are currently doing to end malaria.
The Malaria World Congress comes to a end, the Statement of Action is announced, Olivia Ngou Zangue discusses the role of communities in achieving sustainable health and Peter Sands talks on the urgent need to step up the fight against malaria.
Malaria Researcher, Rima Shretta, estimates the cost of malaria elimination in the Asia Pacific, Unitaid invests in better tools to prevent the misdiagnosis of childhood fevers, more information on the collaborative platform for malaria researchers and WHO shares the need to improve surveillance systems.